FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009794857> ?p ?o ?g. }

• W2009794857 endingPage "206" @default.
• W2009794857 startingPage "187" @default.
• W2009794857 abstract "Trimetrexate is a novel lipophilic folate antagonist that causes growth inhibition, inhibition of nucleic acid biosynthesis, and cytotoxicity at nanomolar concentrations in tissue cultures. The potency of trimetrexate cytotoxicity against most cell lines is greater than that of methotrexate. Trimetrexate has antitumor activity in vivo in several murine leukemia and solid tumor systems, including tumors in which methotrexate is inactive. Antitumor activity was seen following oral, intravenous, or intraperitoneal administration. Trimetrexate causes a pronounced and early depression in incorporation of deoxyuridine into DNA. In tumor cell lines resistant to methotrexate because of a drug transport defect, trimetrexate retains activity. In many such cases the methotrexate-resistant tumors show collateral sensitivity to trimetrexate. In methotrexate-resistant cells with impaired drug transport, trimetrexate sensitivity was even more pronounced when cells were grown in folate-free medium supplemented with physiological levels of tetrahydrofolate cofactor. In the human tumor stem cell colony assay, trimetrexate, at concentrations achievable in vivo, gave activity against many human tumors, including samples that were unresponsive to methotrexate. Trimetrexate crosses the blood-brain barrier, and at very high doses may cause neurotoxicity. At conventional doses the primary toxic effects in mice are gastrointestinal. This toxicity is reversible at therapeutic doses. Unlike earlier lipophilic antifolates, trimetrexate has rapid plasma clearance (t1/2 in mice of 45 minutes). Trimetrexate is a tight-binding competitive inhibitor of dihydrofolate reductase. The Ki,slope for inhibition of the human enzyme was 4 X 10(-11) M. A dose-dependent decrease in cellular purine ribonucleotide pools is given by trimetrexate. Pyrimidine ribonucleotide pools tend to increase in treated cells. Trimetrexate caused a marked depression of cellular pools of dTTP and dGTP, and a lesser depression in dATP. Cytotoxicity of trimetrexate in vitro was prevented by leucovorin. Leucovorin also protected mice from trimetrexate toxicity. Thymidine protected cells from lethal effects of low concentrations of trimetrexate, but not from high concentrations. The combination of thymidine and hypoxanthine completely protected cells from low and high concentrations of trimetrexate. A new, stable and highly water-soluble formulation of trimetrexate has been developed. Because of the interesting biochemical and pharmacological properties of trimetrexate, and its experimental antitumor activity, clinical trials are planned." @default.
• W2009794857 created "2016-06-24" @default.
• W2009794857 creator A5029175020 @default.
• W2009794857 creator A5032973371 @default.
• W2009794857 creator A5033059231 @default.
• W2009794857 creator A5050902667 @default.
• W2009794857 creator A5055702094 @default.
• W2009794857 creator A5079739797 @default.
• W2009794857 creator A5083970959 @default.
• W2009794857 date "1984-01-01" @default.
• W2009794857 modified "2023-09-27" @default.
• W2009794857 title "Biochemical pharmacology of the lipophilic antifolate, trimetrexate" @default.
• W2009794857 cites W1513241457 @default.
• W2009794857 cites W1995376945 @default.
• W2009794857 cites W2004849455 @default.
• W2009794857 cites W2005725046 @default.
• W2009794857 cites W2019113394 @default.
• W2009794857 cites W2020397817 @default.
• W2009794857 cites W2025444976 @default.
• W2009794857 cites W2039785166 @default.
• W2009794857 cites W2077451485 @default.
• W2009794857 cites W2079867668 @default.
• W2009794857 cites W2081623629 @default.
• W2009794857 cites W2258942313 @default.
• W2009794857 cites W2414435754 @default.
• W2009794857 cites W4238923289 @default.
• W2009794857 cites W966789498 @default.
• W2009794857 doi "https://doi.org/10.1016/0065-2571(84)90014-1" @default.
• W2009794857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6236675" @default.
• W2009794857 hasPublicationYear "1984" @default.
• W2009794857 type Work @default.
• W2009794857 sameAs 2009794857 @default.
• W2009794857 citedByCount "92" @default.
• W2009794857 countsByYear W20097948572012 @default.
• W2009794857 countsByYear W20097948572016 @default.
• W2009794857 crossrefType "journal-article" @default.
• W2009794857 hasAuthorship W2009794857A5029175020 @default.
• W2009794857 hasAuthorship W2009794857A5032973371 @default.
• W2009794857 hasAuthorship W2009794857A5033059231 @default.
• W2009794857 hasAuthorship W2009794857A5050902667 @default.
• W2009794857 hasAuthorship W2009794857A5055702094 @default.
• W2009794857 hasAuthorship W2009794857A5079739797 @default.
• W2009794857 hasAuthorship W2009794857A5083970959 @default.
• W2009794857 hasConcept C150903083 @default.
• W2009794857 hasConcept C185592680 @default.
• W2009794857 hasConcept C203014093 @default.
• W2009794857 hasConcept C207001950 @default.
• W2009794857 hasConcept C2778397455 @default.
• W2009794857 hasConcept C2781059491 @default.
• W2009794857 hasConcept C2781320022 @default.
• W2009794857 hasConcept C2781382166 @default.
• W2009794857 hasConcept C55493867 @default.
• W2009794857 hasConcept C86803240 @default.
• W2009794857 hasConcept C98274493 @default.
• W2009794857 hasConceptScore W2009794857C150903083 @default.
• W2009794857 hasConceptScore W2009794857C185592680 @default.
• W2009794857 hasConceptScore W2009794857C203014093 @default.
• W2009794857 hasConceptScore W2009794857C207001950 @default.
• W2009794857 hasConceptScore W2009794857C2778397455 @default.
• W2009794857 hasConceptScore W2009794857C2781059491 @default.
• W2009794857 hasConceptScore W2009794857C2781320022 @default.
• W2009794857 hasConceptScore W2009794857C2781382166 @default.
• W2009794857 hasConceptScore W2009794857C55493867 @default.
• W2009794857 hasConceptScore W2009794857C86803240 @default.
• W2009794857 hasConceptScore W2009794857C98274493 @default.
• W2009794857 hasLocation W20097948571 @default.
• W2009794857 hasLocation W20097948572 @default.
• W2009794857 hasOpenAccess W2009794857 @default.
• W2009794857 hasPrimaryLocation W20097948571 @default.
• W2009794857 hasRelatedWork W1823282561 @default.
• W2009794857 hasRelatedWork W1970602404 @default.
• W2009794857 hasRelatedWork W1979186066 @default.
• W2009794857 hasRelatedWork W2001477230 @default.
• W2009794857 hasRelatedWork W2015414668 @default.
• W2009794857 hasRelatedWork W2054212305 @default.
• W2009794857 hasRelatedWork W2084361397 @default.
• W2009794857 hasRelatedWork W2229599430 @default.
• W2009794857 hasRelatedWork W2233696755 @default.
• W2009794857 hasRelatedWork W66234974 @default.
• W2009794857 hasVolume "22" @default.
• W2009794857 isParatext "false" @default.
• W2009794857 isRetracted "false" @default.
• W2009794857 magId "2009794857" @default.
• W2009794857 workType "article" @default.